Bone drug showdown: which works better for Steroid-Weakened bones?
Disease control
Completed
This study looked at two osteoporosis medications—romosozumab and denosumab—in 54 people who take long-term steroids and have weak bones. Participants first received either romosozumab for 12 months followed by denosumab, or denosumab alone for 24 months. Then everyone stayed on …
Phase: PHASE4 • Sponsor: Tuen Mun Hospital • Aim: Disease control
Last updated Jun 27, 2026 12:29 UTC